Kazia Therapeutics Limited American Depositary Shares
Symbol: KZIA (NASDAQ)
9.82
▼ (-1.41%) -0.140
Company Description:
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
Key Stats
- Today's Open: $9.9
- Today's High: $9.956
- Today's Low: $9.58
- Today's Volume: 10.36K
- Yesterday Close: $9.96
- Yesterday High: $10.31
- Yesterday Low: $9.89
- Yesterday Volume: 23.03K
- Last Min Volume: 10
- Last Min High: $9.82
- Last Min Low: $9.82
- Last Min VWAP: $9.82
Company Profile
- Name: Kazia Therapeutics Limited American Depositary Shares
- Website: https://www.kaziatherapeutics.com
- Listed Date: 1999-01-06
- Location: NEW SOUTH WALES 2113, C3
- Market Status: Active
- CIK Number: 0001075880
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $13.35M
- Round Lot: 100
- Outstanding Shares: 1.36M
- Asset Type: ADRC
RECENT FILINGS FOR KZIA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-25 | 424B3 | View |
| 2025-07-25 | 424B3 | View |
| 2025-07-25 | 424B3 | View |
| 2025-07-25 | 6-K | View |
| 2025-07-25 | 424B5 | View |
| 2025-07-09 | 424B3 | View |
| 2025-07-09 | 424B3 | View |
| 2025-07-09 | 424B3 | View |
| 2025-07-09 | 6-K | View |
| 2025-06-13 | SCHEDULE 13G | View |
| 2025-06-12 | SCHEDULE 13G | View |
| 2025-06-11 | 424B3 | View |
| 2025-06-11 | 424B3 | View |
| 2025-06-11 | 424B3 | View |
| 2025-06-11 | 6-K | View |
| 2025-06-10 | 424B3 | View |
| 2025-06-10 | 424B3 | View |
| 2025-06-10 | 424B3 | View |
| 2025-06-10 | 6-K | View |
| 2025-06-05 | 424B3 | View |
Latest News on KZIA